Back to dashboard
CommercialCoverageMedium impact

08.02.22, Lifileucel (Amtagvi™)

Independence Blue Cross·Oncology·Pharmacy
Effective date
Sep 3, 2025
We identified it
Jun 19, 2026
Days to comply
—

Summary

A commercial insurance policy for Lifileucel (Amtagvi™) has been updated with a reissue effective date of September 3, 2025. This appears to be a pharmacy policy change for this cancer immunotherapy drug, though specific coverage details are not provided in the summary.

Action Required

Action needed
Before September 3, 2025: Billing and pharmacy teams should review the complete policy details at the provided URL to understand any changes to coverage, prior authorization, or billing requirements for Lifileucel (Amtagvi™). Update billing systems and protocols as needed based on the full policy content.

Related policy hubs